AVATAR Group:

Making Vascular Access Complications History

Vascular access device insertion can be difficult and painful. And after insertion, 25% to 50% fail due to infection, blockage, dislodgement or vessel damage.
Our goal is to make vascular access complications history.

The AVATAR Group undertakes committed scientific work to improve health services and patient outcomes, to rigorously and independently test products and practices, and to promote local and global networks and practice development.

We strive to eliminate ineffective practices and replace them with innovative solutions, providing patients with a better healthcare experience and saving global healthcare providers hundreds of millions of dollars.


          

 

AVATAR Group is a member of the Australian Clinical Trials Alliance

     
     
     

 

Contact UsDonate NowTell a FriendBookmark SitePrint